Please assess the completion status of the following clinical trial:

Trial Title: A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy Volunteer~* Body Mass Index of 18.5-25 kilograms per square meter~* Must be able to swallow tablets~* Able to give informed consent~Exclusion Criteria:~* Any DSM-IV TR Axis I psychiatric disorder (except nicotine dependence)~* Presence of any medical disorder that may confound the assessment of relevant biologic measures, including: significant organ system dysfunction, metabolic diseases, type 1 diabetes mellitus, type 2 diabetes mellitus, pregnancy, endocrine disease, coagulopathy, clinically significant anemia, or acute infection~* Subjects who have taken any antipsychotic medication within the last 6 months~* Personal or family history of seizures and/or cardiac arrhythmias

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo
- Olanzapine (Type: EXPERIMENTAL): Olanzapine 10mg po daily x 3 days

Based on this trial design, predict the completion outcome and termination type (if applicable).